Display Settings:

Format

Send to:

Choose Destination
    Neuropsychopharmacology. 2006 Mar;31(3):473-92.

    ACNP Task Force report on SSRIs and suicidal behavior in youth.

    Source

    Columbia University/New York State Psychiatric Institute, New York, NY 10032, USA. jjm@columbia.edu

    Abstract

    This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.

    PMID:
    16319919
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk